JSPR — Jasper Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $81.27m
- $9.63m
Annual cashflow statement for Jasper Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -31.7 | -30.6 | -37.7 | -64.5 | -71.3 |
| Depreciation | |||||
| Non-Cash Items | 12.1 | -5.04 | -8.5 | 6.19 | 7.12 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.3 | 1.62 | -0.649 | 5.1 | 0.173 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -18.3 | -33.7 | -45.9 | -52.1 | -62.6 |
| Capital Expenditures | — | -2.43 | -0.576 | -0.267 | -0.552 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0.02 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | — | -2.43 | -0.576 | -0.267 | -0.532 |
| Financing Cash Flow Items | — | 90 | 0 | -0.96 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 11.3 | 101 | 0.055 | 101 | 47.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.98 | 64.9 | -46.4 | 48.6 | -15.3 |